Related Experiment Videos
Pinacidil: history, basic pharmacology, and therapeutic implications
1Department of Pharmacology, Leo Pharmaceutical Products, Ballerup, Denmark.
Journal of Cardiovascular Pharmacology
|January 1, 1988
Summary
Pinacidil, a novel antihypertensive drug, effectively lowers blood pressure by opening potassium channels, causing vasodilation. It is well-absorbed orally and shows selectivity for precapillary vessels with manageable side effects.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
Background:
- Peripheral vasodilation is a key strategy for hypertension management.
- Existing vasodilators include calcium antagonists, alpha-adrenergic antagonists, and ACE inhibitors.
Observation:
- A new class of vasodilators, pyridylthioureas, demonstrated antihypertensive activity.
- Chemical modifications led to pinacidil (N -cyano-N-(4-pyridyl)-N"-(1,2,2-trimethylpropyl) guanidine), a potent antihypertensive agent.
Findings:
- Pinacidil functions by opening potassium channels in cell membranes, inducing hyperpolarization and vascular smooth muscle relaxation.
- It is rapidly absorbed orally, producing dose-dependent blood pressure reduction in hypertensive models and humans.
- Pinacidil selectively increases coronary blood flow and decreases vascular resistance, particularly in precapillary vessels.
Implications:
- Pinacidil represents a novel mechanism for hypertension treatment via potassium channel activation.
- Its favorable pharmacokinetic profile and manageable side effects suggest therapeutic potential.
- Further research may explore its role in managing various cardiovascular conditions.